MicroMatrices’ R&D-based technology program feeds back into our service offerings to keep services as current and competitive as possible. Our SpheroMatrices knowledge service, described below, illustrates this transition from innovation into a service product.
The SpheroMatrices technology we developed forms the basis for a platform of applications developed for 3D spheroid models for brain, liver and kidney, with future applications for skin, patient-derived explant (PDX) tumours under development.
Spheroid Tissue Microarray
A spheroid tissue microarray for obtaining medium-high throughput toxicity/efficacy data from human relevant organotypic spheroid cultures.
For precise quantitation of protein biomarkers located to tissue subregions providing drug outcome ranking parameters linked to complex mode of action insights; performed using FFPE samples.
on an interactive, step by step basis. Collaborations can begin with pilot projects which can then be scaled up to larger research programs, according to your requirements.